FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Somerset Therapeutics Brimonidine Tartrate Opthalmic Solution 0 Recall

Brimonidine Tartrate Opthalmic Solution 0

SOMERSET THERAPEUTICS LLC · Somerset, NJ

Risk level
Class III
Reported by FDA
Jul 15, 2020
Recall ID
D-1375-2020
Check your lot numberHow we source this data

Summary

Somerset Therapeutics recalled Brimonidine Tartrate Opthalmic Solution 0 starting Jun 4, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1375-2020 on Jul 15, 2020. Reason: Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.

Product description

Brimonidine Tartrate Opthalmic Solution 0.2%, 15 mL bottle, Rx only, Manufactured for: Somerset Therapeutics, LLC Hollywood, FL 33024. Made in India. NDC 70069-233-01

Lot numbers, UPCs & expiration codes

Lot #s BRM13W9001, BRM13W9002, BRM13W9003, EXP Dec. 2020: BRM13W9004, EXP Apr. 2021.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1375-2020
Classification
Class III
Status
Terminated
Recall initiated
Jun 4, 2020
FDA report date
Jul 15, 2020
Quantity
22,788 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
SOMERSET THERAPEUTICS LLC

Original FDA data

Every field from FDA enforcement report D-1375-2020, exactly as published.

Show all FDA fields
City
Somerset
State
NJ
Status
Terminated
Country
United States
Event ID
85826
Address
300 Franklin Square Dr
Code information
Lot #s BRM13W9001, BRM13W9002, BRM13W9003, EXP Dec. 2020: BRM13W9004, EXP Apr. 2021.
Postal code
08873-4187
Report date
Jul 15, 2020
Product type
Drugs
Recall number
D-1375-2020
Classification
Class III
Recalling firm
SOMERSET THERAPEUTICS LLC
Product quantity
22,788 bottles
Termination date
Jun 30, 2023
Reason for recall
Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Brimonidine Tartrate Opthalmic Solution 0.2%, 15 mL bottle, Rx only, Manufactured for: Somerset Therapeutics, LLC Hollywood, FL 33024. Made in India. NDC 70069-233-01
Distribution pattern
Nationwide
Recall initiation date
Jun 4, 2020
Initial firm notification
Letter
Center classification date
Jul 7, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1375-2020, published Jul 15, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls